MD Training, Specialty Affect Menopause Treatments

The North American Menopause Society Advisory Panel has announced the release of their 2023 position statement on nonhormonal therapy for menopause.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

At the 2023 ACOG Annual Clinical & Scientific Meeting, the safety and efficacy of compounded bioidentical hormone therapy for menopause were discussed.

Actress Kim Cattrall discusses her menopause journey and partnership with Tune In To Menopause, an awareness campaign designed to empower women.

What the obstetrician-gynecologist should know

In a recent study, menopausal vasomotor symptoms were successfully treated using the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer).